Conflixis
PrivateLast Round
Seed
Nov 8, 2024
Total Funding Raised
$4.48M
Momentum Score
25 /100
Company Overview
Conflixis is a business/productivity software company that has developed an AI-powered risk management platform for identifying and managing conflicts of interest, primarily for the healthcare industry.
Sector
Healthcare & Life Sciences
Verticals
Compliance & Risk, Vertical SaaS, Medical AI, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Conflixis Comps
Public and private peers based on sector, stage, and business model.
Conflixis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 8, 2024 | ||||
| Convertible Debt | Jan 25, 2024 |
Key People
Founding team and executive leadership
Conflixis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SpringTime Ventures | Seed |
| Mark VC | Seed |
| Lerer Hippeau | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 28, 2025
Judy Ringholz joins as Senior Managing Director.
Conflixis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Conflixis's valuation, stock price, and market status.
